Patents by Inventor Roger Corder

Roger Corder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11116747
    Abstract: The present application concerns compositions comprising ellagitannins and proanthocyanidins, and the use of such compositions for preventing or treating endothelial dysfunction. The compositions of the invention comprise at least one ellagitannin in combination with at least one proanthocyanidin. The present application also concerns methods of treating, preventing, or delaying the onset of endothelial dysfunction using compositions comprising ellagitannins and proanthocyanidins.
    Type: Grant
    Filed: April 2, 2019
    Date of Patent: September 14, 2021
    Inventor: Roger Corder
  • Publication number: 20190224163
    Abstract: The present application concerns compositions comprising ellagitannins and proanthocyanidins, and the use of such compositions for preventing or treating endothelial dysfunction. The compositions of the invention comprise at least one ellagitannin in combination with at least one proanthocyanidin. The present application also concerns methods of treating, preventing, or delaying the onset of endothelial dysfunction using compositions comprising ellagitannins and proanthocyanidins.
    Type: Application
    Filed: April 2, 2019
    Publication date: July 25, 2019
    Applicant: Nugerontix Limited
    Inventor: Roger Corder
  • Patent number: 10285970
    Abstract: The present application concerns compositions comprising ellagitannins and proanthocyanidins, and the use of such compositions for preventing or treating endothelial dysfunction. The compositions of the invention comprise at least one ellagitannin in combination with at least one proanthocyanidin. The present application also concerns methods of treating, preventing, or delaying the onset of endothelial dysfunction using compositions comprising ellagitannins and proanthocyanidins.
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: May 14, 2019
    Assignee: Nugerontix Limited
    Inventor: Roger Corder
  • Publication number: 20170216245
    Abstract: The present application concerns polyphenol compositions, and the use of such compositions for preventing or treating endothelial dysfunction. The polyphenol compositions of the invention comprise at least one ellagitannin in combination with at least one proanthocyanidin.
    Type: Application
    Filed: July 24, 2015
    Publication date: August 3, 2017
    Applicant: Nugerontix Limited
    Inventor: Roger Corder
  • Patent number: 7423141
    Abstract: Sequences in human preproendothelin-1 mRNA are described against which antisense oligonucleotides can be used to inhibit the synthesis of endothelin-1. This inhibition of endothelin-1 synthesis may be used to treat diseases where excess production of endothelin-1 is an underlying cause of the symptoms.
    Type: Grant
    Filed: November 18, 2002
    Date of Patent: September 9, 2008
    Assignee: William Harvey Research Ltd.
    Inventors: Roger Corder, Adrian P. L. Smith, Timothy W. Higgenbottam, Martine Rothblatt, John Vane, Delphine Dominique Marthe Lees
  • Publication number: 20030109480
    Abstract: Sequences in human preproendothelin-1 mRNA are described against which antisense oligonucleotides can be used to inhibit the synthesis of endothelin-1. This inhibition of endothelin-1 synthesis may be used to treat diseases where excess production of endothelin-1 is an underlying cause of the symptoms.
    Type: Application
    Filed: November 18, 2002
    Publication date: June 12, 2003
    Applicant: United Therapeutics Corporation
    Inventors: Roger Corder, Adrian P.L. Smith, Timothy W. Higenbottam, Martine Rothblatt, Sir John Vane, Delphine Dominique Marthe Lees